About the Company
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RGEN News
V Square Quantitative Management LLC Has $31,000 Stake in Repligen Co. (NASDAQ:RGEN)
V Square Quantitative Management LLC lowered its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 70.0% in the third ...
Repligen Corporation (RGEN)
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be ...
Repligen (RGEN) Receives a Buy from J.P. Morgan
In a report released yesterday, Rachel Vatnsdal from J.P. Morgan maintained a Buy rating on Repligen (RGEN – Research Report), with a ...
Repligen Corp.
U.S. News' panel of financial advisors addresses the No. 1 issue on investors' minds in the back half of 2024.
Evaluating Repligen: Insights From 6 Financial Analysts
Stay up to date on Repligen analyst ratings. All You Need to Know About Repligen Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing ...
Repligen (RGEN) Receives a Buy from RBC Capital
Begin your TipRanks Premium journey today. Repligen (RGEN) Company Description: Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing ...
Repligen: Initiating Coverage With Narrow Moat Rating and $180 FVE; Shares Undervalued
We are initiating coverage of Repligen with a narrow moat rating and fair value estimate of $180 per share. The firm is a leading provider of bioprocessing solutions for companies manufacturing ...
Repligen Opens Training & Innovation Center to Elevate Customer Experience
WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of ...
RGEN Quantitative Stock Analysis
Below is Validea's guru fundamental report for REPLIGEN CORP (RGEN). Of the 22 guru strategies we follow, RGEN rates highest using our Low PE Investor model based on the published strategy of John ...
Repligen's SWOT analysis: bioprocessing leader's stock faces growth hurdles
Repligen (NASDAQ:RGEN) Corporation (NASDAQ:RGEN), a key player in the pharmaceutical development, manufacturing, and bioprocessing sector, has been navigating a complex market landscape characterized ...
Repligen Corp (RGN.BE)
WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its ...
Loading the latest forecasts...